202 related articles for article (PubMed ID: 35464825)
1. IL-6 Signaling Link between Inflammatory Tumor Microenvironment and Prostatic Tumorigenesis.
Ene CV; Nicolae I; Geavlete B; Geavlete P; Ene CD
Anal Cell Pathol (Amst); 2022; 2022():5980387. PubMed ID: 35464825
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.
Valencia T; Kim JY; Abu-Baker S; Moscat-Pardos J; Ahn CS; Reina-Campos M; Duran A; Castilla EA; Metallo CM; Diaz-Meco MT; Moscat J
Cancer Cell; 2014 Jul; 26(1):121-135. PubMed ID: 25002027
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue.
Liu G; Zhang J; Frey L; Gang X; Wu K; Liu Q; Lilly M; Wu J
J Hematol Oncol; 2017 Jan; 10(1):14. PubMed ID: 28077171
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.
Krušlin B; Tomas D; Džombeta T; Milković-Periša M; Ulamec M
Front Oncol; 2017; 7():77. PubMed ID: 28487844
[TBL] [Abstract][Full Text] [Related]
6. A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth.
Yu SH; Maynard JP; Vaghasia AM; De Marzo AM; Drake CG; Sfanos KS
Prostate; 2019 Feb; 79(2):215-222. PubMed ID: 30345534
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate.
Handisurya A; Steiner GE; Stix U; Ecker RC; Pfaffeneder-Mantai S; Langer D; Kramer G; Memaran-Dadgar N; Marberger M
Prostate; 2001 Dec; 49(4):251-62. PubMed ID: 11746271
[TBL] [Abstract][Full Text] [Related]
8. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.
Simons BW; Durham NM; Bruno TC; Grosso JF; Schaeffer AJ; Ross AE; Hurley PJ; Berman DM; Drake CG; Thumbikat P; Schaeffer EM
J Pathol; 2015 Feb; 235(3):478-89. PubMed ID: 25348195
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
Fibbi B; Penna G; Morelli A; Adorini L; Maggi M
Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330
[TBL] [Abstract][Full Text] [Related]
10. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.
Norström MM; Rådestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
Oncotarget; 2016 Apr; 7(17):23581-93. PubMed ID: 26993768
[TBL] [Abstract][Full Text] [Related]
11. The IL-4/IL-13 signaling axis promotes prostatic fibrosis.
D'Arcy Q; Gharaee-Kermani M; Zhilin-Roth A; Macoska JA
PLoS One; 2022; 17(10):e0275064. PubMed ID: 36201508
[TBL] [Abstract][Full Text] [Related]
12. IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.
Rojas A; Liu G; Coleman I; Nelson PS; Zhang M; Dash R; Fisher PB; Plymate SR; Wu JD
Oncogene; 2011 May; 30(20):2345-55. PubMed ID: 21258401
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
14. Age-related increase in IL-17 activates pro-inflammatory signaling in prostate cells.
De Angulo A; Faris R; Daniel B; Jolly C; deGraffenried L
Prostate; 2015 Apr; 75(5):449-62. PubMed ID: 25560177
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
16. The inflammatory microenvironment and microbiome in prostate cancer development.
Sfanos KS; Yegnasubramanian S; Nelson WG; De Marzo AM
Nat Rev Urol; 2018 Jan; 15(1):11-24. PubMed ID: 29089606
[TBL] [Abstract][Full Text] [Related]
17. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
Qu X; Tang Y; Hua S
Front Immunol; 2018; 9():563. PubMed ID: 29662489
[TBL] [Abstract][Full Text] [Related]
18. Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate.
McIlwain DW; Zoetemelk M; Myers JD; Edwards MT; Snider BM; Jerde TJ
Prostate; 2016 Jun; 76(8):722-34. PubMed ID: 27088546
[TBL] [Abstract][Full Text] [Related]
19. Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.
Zhang M; Lin D; Luo C; Wei P; Cui K; Chen Z
Oxid Med Cell Longev; 2022; 2022():1247806. PubMed ID: 35154561
[TBL] [Abstract][Full Text] [Related]
20. Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland.
Rodríguez-Berriguete G; Prieto A; Fraile B; Bouraoui Y; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
Eur Cytokine Netw; 2010 Dec; 21(4):241-50. PubMed ID: 21081304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
